Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 26-34

  Kaya, Pelin ^a   Gündüz, Ufuk ^a   Arpaci, Fikret ^b   Ural, Ali Uĝur ^b   Guran, Sefik ^b  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute leukemia; MDR1; P glycoprotein; Single nucleotide polymorphism; SNP

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CYTARABINE; CYTOSINE; DAUNORUBICIN; DEXAMETHASONE; GENE PRODUCT; GLYCOPROTEIN P; GUANINE; RETINOIC ACID; THYMINE; VINCRISTINE;

ACUTE LEUKEMIA; ADULT; AFRICA; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CAUCASIAN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG SENSITIVITY; GENE; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HOMOZYGOSITY; HUMAN; JAPAN; MDR1 GENE; MULTIDRUG RESISTANCE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ACUTE DISEASE; ANTIGENS, CD; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; TURKEY;

EID: 24344464248     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20427     Document Type: Article

References (20)

1. Deuchars KL, Ling V. P-Glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 1989;16(2):156-165.
2. Slovak ML, Ho JP, Cole SPC, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res 1995;55:4214-4219.
3. Gupta S, Tsuruo T. Multidrug resistance in cancer cells. Molecular biochemical physiological and biological aspects. New York: John Wiley & Sons; 1996. 507 p.
4. Michieli M, Damiani D, Ermacora A, et al. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo non-lymphocytic leukemias: biological and clinical implications. Br J Haematol 1999;104(2):328-335.
5. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 2000;60(1):47-50.
6. Thorgiersson SS, Silverman JA, Gant TW, Marino PA. Multidrug resistance gene family and chemical carcinogens. Pharmacol Ther 1991;49(3):283-292.
7. Chen CI, Chin JE, Ueda K, Clark DP, Gottesman MM, Roninson IB. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells. Cell 1986;47(3):381-389.
8. Chen CJ, Clark DP, Ueda K, Gottesman MM, Roninson IB. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem 1990;265(1):506-514.
9. Ueda K, Clark DP, Chen CI, Roninson IB, Gottesman MM, Pastan I. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 1987;262(2):505-508.
10. Fojo AT, Shen DW, Mickley LA, Pastan I, Gottesman MM. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug resistance gene. J Clin Oncol 1987;5(12):1922-1927.
11. Fojo AT, Ueda K, Slaman DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84(1):265-269.
12. Hitchins RN, Harman DH, Davey RA, Bell DR. Identification of a multidrug resistance associated antigen (P-glycoprotein) in normal human tissues. Eur J Cancer Clin Oncol 1988;24(3):449-454.
13. Haber DA. Multidrug resistance (MDR1) in leukemia: is it time to test? Blood 1992;79(2):295-298.
14. Weinstein RS, Kuszak JR, Kluskens LF, Coon JS. The multidrug resistance gene family: P-glycoprotein in pathology. Hum Pathol 1990;21(1):34-48.
15. Ameyaw MM, Regaterio F, Li T, et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001;11:217-221.
16. Hoffmeyer S, Burk O, Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97(7):3473-3478.
17. Tanabe M, Ieri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR1) gene. J Pharmacol Exp Ther 2001;297(3):1137-1143.
18. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001;69(3):169-174.
19. Hitzl M, Drescher S, Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001;11:293-298.
20. Estey E. Treatment of refractory AML. Leukemia 1996;10(6):932-936.